Overjet Secures $7.85M Seed Funding to Advance AI-Powered Dental Solutions

VCBeat (WeChat ID: vcbeat) has learned that Overjet announced on June 2 (local time) the completion of a $7.85 million seed financing round. The round was led by Crosslink Capital, with participation from E14 Fund. The funds will be used for the company’s research and development of AI-powered dental products.

It is worth noting that the E14 Fund invests exclusively in startups originating from the Massachusetts Institute of Technology (MIT). Wardah Inam, CEO of Overjet, holds a Ph.D. in Electrical Engineering and Computer Science from MIT.

Selecting Crosslink as the lead investor was no accident. Inam stated, “Overjet chose to raise funding from Crosslink because it had previously invested in Weave, whose software is commonly used in the dental field.” According to foreign media reports, Weave secured $70 million in its Series D financing round in 2019.

In 2018, Wardah Inam founded the company in Cambridge, Massachusetts. Overjet is a software company whose platform is designed to reduce costs and improve the quality of dental care. The platform uses artificial intelligence technology to analyze dental data to determine what treatment patients need. Its computer vision and machine learning algorithms have improved patient dental care.

When you visit the dentist, they will typically perform an X-ray examination of your teeth, review the images, and provide recommendations. They may tell you that your dental health is excellent and advise you to return for a cleaning in a few months. Alternatively, your dentist may indicate that treatment is necessary. The latter scenario is where Overjet comes into play.

Overjet has two major advantages. First, its automated claims review capability automatically analyzes data to reduce the number of claims requiring dentist review, thereby shortening turnaround time and lowering costs. Second, it leverages clinical data for practice optimization. Overjet’s clinically optimized software analyzes patients’ clinical presentations to identify areas for improvement, further enhancing patient care, helping practices pinpoint key areas for growth, and increasing profitability.

The CEO stated in an interview with the media, “Most AI medical imaging services focus on detecting whether a patient has an issue, but Overjet can go a step further to assess the severity of the problem itself.” As Overjet’s CEO noted, this capability to “analyze clinical data at scale” and “determine necessary treatments” holds potential appeal for both dentists and insurance companies.

For dentists, Overjet leverages artificial intelligence to assist in diagnosis and help identify issues that are easily overlooked. For insurance companies, Overjet can also expedite the processing of the large volume of incoming dental images. Inam stated, “Every dental image submitted to major insurance companies is manually reviewed, a process that is complex. Artificial intelligence may be able to determine more accurately and quickly whether claims are legitimate rather than fraudulent, thereby better improving patient care.”

Crosslink Capital is a leading early-stage venture capital firm with approximately $1.6 billion in assets under management. Tracing its roots back to 1989, Crosslink is one of the earliest and largest investment firms in the United States, integrating public and private savings and investments across three fund types: venture capital funds, long/short hedge funds, and a unique hybrid cross-over fund. This strategy enables Crosslink to maintain long-term partnerships with its portfolio companies.

E14 Fund is an advisory team composed of investors, industry experts, and entrepreneurs. It cultivates entrepreneurs from the Massachusetts Institute of Technology (MIT) and helps them connect with investors and industry experts to scale product prototypes and ultimately secure additional funding. E14 Fund supports companies across various sectors, ranging from biotechnology and smart cities to consumer electronics and manufacturing.